Myeloproliferative Erkrankungen der Haut

DMBT1 expression distinguishes anorectal from cutaneous melanoma

“…5 All analysed cases of AM showed cellular differentiation and pigmentation comparable to that in cutaneous and other mucosal melanoma of different localization. 3,19 Moreover, immunopositivity for the classical melanoma markers S100, HMB-45, Melan A and MiTF was virtually identical to that of melanoma located elsewhere. 20 The vast majority (19 ⁄ 27) of the AM cases displayed DMBT1 expression in >10% of the tumour cells.…”

Nachruf

“…• "A legend in his time" (St. I. Katz, 16 th International Symposium of the ISDP, Cancun, Mexico 1995) • "… will be featured as one of the most prominent figures of all time in dermatology and dermatopathology" [2] • "… ist ein Genie der Gestaltwahrnehmung" [3] • "Founding figure in the field of dermatopathology" (J. Hoffman, New York Times, December 11, 2008 [8] Bernie gewidmet und im Vorwort unsere Gedanken im Geiste aller seiner Schüler in folgender Weise formuliert: "For A. Bernard Ackerman, who helped us to learn principles of dermatopathology, motivated us to pursue the discipline with passion, independence and honesty, inspired us to aspire beyond our possibilities and enabled us to understand that friendship enhances both, collaboration and life." Bernie war unnachgiebig zu sich selbst und streng zu seinen "fellows" bzw.…”

Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas

“…In some cases an explicit diagnosis of cutaneous malignant melanoma cannot be made either according to morphology or to the immunocytochemical labelling pattern of established markers such as HMB-45 or Melan-A, 1 because only a few molecules are reported to be expressed exclusively in melanomas but not in melanocytic naevi, e.g. vascular endothelial growth factor (VEGF).…”